Statistics for Medexus Pharmaceuticals Inc. (id:13854 MDP)
Valuation metrics
Market cap
53.00M
Enterprise value
123.02M
Trailing P/E (ttm)
16.54
Forward P/E
-107.50
PEG ratio
-107.50
Price/Sales (ttm)
0.51
Price/Book (mrq)
1.62
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
4.76
Overview
Shares outstanding
24.65M
Float
22.29M
Shares short
63.46K
% Held by insiders
0.09%
% Held by institutions
0.08%
Average volume (10 days)
64.35K
Average volume (90 days)
Price summary
52-Week low
1.44
52-Week high
3.16
52-Week change
28.64%
Beta
1.95
50-Day moving average
2.48
200-Day moving average
2.05
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
December 19th, 2018
Ex-dividend date
Last split factor
2:1
Last split date
December 19th, 2018
Financials
Fiscal yearFiscal year ends
March 31th, 2024
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
2.19%
Operating margin
15.59%
Operational effectiveness
Return on assets
5.14%
Return on equity
8.42%
Income statement
Revenue (ttm)
4.29
Revenue per share (ttm)
4.29
Quarterly revenue growth (yoy)
Gross profit (ttm)
59.51M
EBITDA
18.71M
Net income to common (ttm)
3.21M
Diluted EPS (ttm)
0.13
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
9.75M
Total cash per share (mrq)
0.28
Total debt (mrq)
60.06M
Total Debt/Equity (mrq)
131.25
Current ratio (mrq)
101.20%
Book value per share (mrq)
1.33
Cash flow
Cash flow statement
31.02M
Levered free cash flow (LFCF)
12.88M